Legal & General Group Plc Takes $2.29 Million Position in Aehr Test Systems $AEHR

Legal & General Group Plc bought a new position in Aehr Test Systems (NASDAQ:AEHRFree Report) in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The firm bought 23,821 shares of the semiconductor company’s stock, valued at approximately $2,288,000.

Several other institutional investors have also recently made changes to their positions in AEHR. Royal Bank of Canada grew its holdings in Aehr Test Systems by 262.7% during the 1st quarter. Royal Bank of Canada now owns 50,207 shares of the semiconductor company’s stock valued at $365,000 after purchasing an additional 36,364 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its stake in Aehr Test Systems by 8.5% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 17,225 shares of the semiconductor company’s stock worth $126,000 after purchasing an additional 1,344 shares during the last quarter. JPMorgan Chase & Co. lifted its stake in Aehr Test Systems by 7.9% in the second quarter. JPMorgan Chase & Co. now owns 15,576 shares of the semiconductor company’s stock worth $201,000 after purchasing an additional 1,145 shares during the last quarter. Rhumbline Advisers lifted its stake in Aehr Test Systems by 3.1% in the second quarter. Rhumbline Advisers now owns 41,466 shares of the semiconductor company’s stock worth $536,000 after purchasing an additional 1,254 shares during the last quarter. Finally, American Century Companies Inc. boosted its position in shares of Aehr Test Systems by 88.1% during the second quarter. American Century Companies Inc. now owns 22,106 shares of the semiconductor company’s stock valued at $286,000 after buying an additional 10,354 shares during the period. Institutional investors own 69.69% of the company’s stock.

Aehr Test Systems Trading Up 13.1%

AEHR opened at $86.26 on Friday. The company has a market capitalization of $2.81 billion, a price-to-earnings ratio of -359.40 and a beta of 3.06. Aehr Test Systems has a 12-month low of $18.70 and a 12-month high of $147.40. The business’s fifty day simple moving average is $90.39 and its 200-day simple moving average is $78.66.

Analyst Upgrades and Downgrades

A number of research analysts have recently commented on the company. Jefferies Financial Group began coverage on Aehr Test Systems in a research note on Thursday, August 13th. They set a “buy” rating and a $175.00 target price on the stock. Lake Street Capital reissued a “buy” rating and set a $110.00 price target on shares of Aehr Test Systems in a research note on Wednesday, July 15th. Zacks Research upgraded Aehr Test Systems from a “hold” rating to a “strong-buy” rating in a report on Friday, July 17th. Craig Hallum reaffirmed a “buy” rating and issued a $125.00 price objective on shares of Aehr Test Systems in a research report on Wednesday, July 15th. Finally, Wall Street Zen upgraded Aehr Test Systems from a “sell” rating to a “hold” rating in a research note on Saturday, July 18th. Two equities research analysts have rated the stock with a Strong Buy rating, four have given a Buy rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the company currently has an average rating of “Buy” and an average target price of $136.67.

Check Out Our Latest Research Report on AEHR

Insider Activity at Aehr Test Systems

In other Aehr Test Systems news, EVP Alberto Salamone sold 9,672 shares of the stock in a transaction dated Thursday, August 13th. The shares were sold at an average price of $127.72, for a total transaction of $1,235,307.84. Following the transaction, the executive vice president directly owned 41,962 shares in the company, valued at $5,359,386.64. This represents a 18.73% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Howard Slayen sold 20,000 shares of the business’s stock in a transaction dated Tuesday, August 4th. The shares were sold at an average price of $108.30, for a total transaction of $2,166,000.00. Following the completion of the sale, the director owned 146,367 shares of the company’s stock, valued at approximately $15,851,546.10. This represents a 12.02% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 109,475 shares of company stock worth $13,827,160 over the last quarter. Corporate insiders own 6.80% of the company’s stock.

Aehr Test Systems Profile

(Free Report)

Aehr Test Systems develops, manufactures and sells semiconductor test and burn-in equipment used by device manufacturers to ensure quality and reliability of integrated circuits. Its products are designed for wafer-level reliability assessment, functional test and stress screening of memory devices, system-on-chips, optical components and power semiconductors. By focusing on wafer-level burn-in and testing processes, the company helps reduce cost and improve yield for high-volume semiconductor production.

The company’s product portfolio includes FOX series wafer probe test and burn-in systems as well as ABTS burn-in ovens.

Featured Stories

Want to see what other hedge funds are holding AEHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aehr Test Systems (NASDAQ:AEHRFree Report).

Institutional Ownership by Quarter for Aehr Test Systems (NASDAQ:AEHR)

Receive News & Ratings for Aehr Test Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aehr Test Systems and related companies with MarketBeat.com's FREE daily email newsletter.